TuisBSX • NYSE
add
Boston Scientific Corporation
Vorige sluiting
$89,25
Dagwisseling
$89,10 - $90,39
Jaarwisseling
$53,93 - $91,93
Markkapitalisasie
134,07 mjd USD
Gemiddelde volume
6,92 m
P/V-verhouding
74,57
Dividend-opbrengs
-
Primêre beurs
NYSE
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(USD) | Sep. 2024info | J/J-verandering |
---|---|---|
Inkomste | 4,21 mjd | 19,34% |
Bedryfskoste | 2,17 mjd | 20,38% |
Netto inkomste | 469,00 m | -7,13% |
Netto winsgrens | 11,14 | -22,21% |
Wins per aandeel | 0,63 | 26,00% |
EBITDA | 1,02 mjd | 12,65% |
Effektiewe belastingkoers | 29,90% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
(USD) | Sep. 2024info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | 2,50 mjd | 162,82% |
Totale bates | 38,08 mjd | 11,85% |
Totale aanspreeklikheid | 17,12 mjd | 14,80% |
Totale ekwiteit | 20,96 mjd | — |
Uitstaande aandele | 1,47 mjd | — |
Prys om te bespreek | 6,35 | — |
Opbrengs op bates | 4,77% | — |
Opbrengs op kapitaal | 5,63% | — |
Kontantvloei
Netto kontantverandering
(USD) | Sep. 2024info | J/J-verandering |
---|---|---|
Netto inkomste | 469,00 m | -7,13% |
Kontant van bedrywe | 1,00 mjd | 43,55% |
Kontant van beleggings | -1,43 mjd | -624,37% |
Kontant van finansiering | 7,00 m | -56,25% |
Netto kontantverandering | -412,00 m | -180,31% |
Beskikbare kontantvloei | 612,38 m | 43,29% |
Meer oor
Boston Scientific Corporation, headquartered in Marlborough, Massachusetts and incorporated in Delaware, is a biomedical/biotechnology engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology. Boston Scientific is widely known for the development of the Taxus Stent, a drug-eluting stent which is used to open clogged arteries. With the full acquisition of Cameron Health in June 2012, the company also became notable for offering a minimally invasive implantable cardioverter-defibrillator which they call the EMBLEM subcutaneous implantable defibrillator. Wikipedia
Gestig
29 Jun. 1979
Webwerf
Werknemers
48 000